HIV & AIDS

What you need to know about HIV/AIDS today

More than 60,000 Canadians and 37 million people worldwide are living with HIV. In the early days of HIV and AIDS, there was enormous fear and discrimination —to the extent that in British Columbia politicians debated ...

HIV & AIDS

The perception of PrEP as an excuse for promiscuity

In 2012, the FDA approved the use of the drug emtricitabine/tenofovir disoproxil fumarate ('Truvada') as an HIV Pre-exposure Prophylaxis (PrEP) to reduce the risk of HIV infection in the event of exposure. Taking daily PrEP ...

HIV & AIDS

Study finds barriers to accessing HIV prevention pill

APLA Health, in partnership with the California HIV/AIDS Research Program (CHRP) of the University of California, today (Sept. 12) released a new report on pre-exposure prophylaxis (PrEP) titled "Addressing PrEP Disparities ...

page 4 from 17